UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Display

results per page

Results 136 - 150 of 671

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Sacral Neuromodulation with Implanted Devices for Urinary Storage and Voiding Dysfunction in Adults - Abstract
Thursday, 21 May 2009
Department of Preventive & Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand, 9054.
read more

Urinary Nerve Growth Factor is a Better Biomarker than Detrusor Wall Thickness for the Assessment of Overactive Bladder With Incontinence - Abstract
Wednesday, 20 May 2009
Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.
read more

The Total Economic Burden of Overactive Bladder in the United States: A Disease-Specific Approach - Abstract
Tuesday, 19 May 2009
Department of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA.
read more

Pharmacotherapy Adherence and Costs Versus Nonpharmacologic Management in Overactive Bladder - Abstract
Tuesday, 19 May 2009
Health Economics and Outcomes Research, IMS Health, Inc., 311 Arsenal St, The Arsenal on the Charles, Watertown, MA 02472, USA.
read more

UIJ - Efficacy and Tolerability of Add-On Trospium Chloride in Patients with Benign Prostate Syndrome and Overactive Bladder: A Noninterventional Trial Showing Use of Flexible Dosing - Abstract
Monday, 18 May 2009
Dr. R. Pfleger GmbH, D-96045 Bamberg.
read more

The Overlap of Storage, Voiding and Postmicturition Symptoms and Implications for Treatment Seeking in the USA, UK and Sweden: EpiLUTS - Abstract
Friday, 15 May 2009
United BioSource Corporation, Bethesda, MD 20814, USA.
read more

UIJ - A Randomized Controlled Study of Posterior Tibial Nerve Stimulation for Overactive Bladder - Abstract
Friday, 15 May 2009
Department of Urology, Rua Jose Pugliesi Filho 265, Campinas, Sao Paulo, Brazil 13085-415.
read more

BJUI Mini Reviews - On the Origins of the Sensory Output from the Bladder: The Concept of Afferent Noise
Wednesday, 13 May 2009
This review examines the diversity of the bladder afferent system and explores the underlying complexity between afferent and sensory information.
Login to read more...

Two Types of Urgency - Abstract
Monday, 11 May 2009
Weill Cornell Medical College, New York, New York 10021, USA.
read more

AUA 2009 - Botulinum Toxin A (BOTOX®) Demonstrates Dose-Dependent Improvements in Health-Related Quality-of-Life Measures in Idiopathic Overactive Bladder - Poster
Thursday, 07 May 2009
CHICAGO, IL, USA (UroToday.com) - This double-blind, placebo-controlled, Phase 2, dose-ranging study assessed the effects of BOTOX® treatment for patients with idiopathic OAB and UUI inadequately managed with anticholinergics.
Login to read more...

On the Origins of the Sensory Output from the Bladder: The Concept of Afferent Noise - Abstract
Thursday, 07 May 2009
The Uro-physiology Research Group, the Medical School, the University, Newcastle upon Tyne, UK.
read more

Solifenacin Succinate for the Treatment of Overactive Bladder - Abstract
Wednesday, 06 May 2009
Saint Louis University, School of Medicine, Department of Obstetrics, Gynecology and Women's Health, St. Louis, MO 63117, USA.
read more

Percutaneous Tibial Nerve Stimulation for Treatment of Overactive Bladder and Urinary Retention in an Elderly Population - Abstract
Tuesday, 05 May 2009
Center for Bladder and Pelvic Floor Health, ProHealth Care Incorporated, Waukesha Memorial Hospital, Waukesha, WI, USA.
read more

"We Have to Stop Again?!": The Impact of Overactive Bladder on Family Members - Abstract
Monday, 04 May 2009
United BioSource Corporation, Bethesda, Maryland.
read more

AUA 2009 - Urodynamics/Incontinence/Female Urology: Urodynamic Testing - Defining the Educational Gap in Urodynamics Training Between Residency and the First 18 Months in Practice - Session Highlights
Friday, 01 May 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Beth Mueller presented interesting data on the rising use of urodynamics and the gap between the urodynamic experience of residents and the use of the study in the first 18 months of practice.
read more

Focus on Overactive Bladder

Focus on Overactive Bladder condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Podcast - Effective Darifenacin Treatment after Dissatisfaction with Prior Extended-Release Antimuscarinic Therapy

World Continence Week 2009

Patient Guide - Controlling Your Bladder Symptoms

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Promoting Continence Worldwide

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Urinary Incontinence: Epidemiology and Disease Burden
- Prepared by Alan J. Wein, MD, PhD (hon)

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years
- by Brian Olshansky, MD

Darifenacin Treatment for Overactive Bladder in Patients Who Expressed Dissatisfaction With Prior Extended-Release Antimuscarinic Therapy
- by Norman Zinner, MD, et al.

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
- by Alexander Roosen, MD and Clare J. Fowler, MD

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder
- by Giacomo Novara, MD, FEBU

Emerging Drugs for Treatment of Overactive Bladder and Detrusor Overactivity
- by Marcus Drake, MD

Two Types of Urgency
- by Philip M. Hanno, MD, MPH - Editor's Pick

Long-Term Efficacy and Safety of Tolterodine in Children with Neurogenic Detrusor Overactivity
- by Pasquale Casale, MD

Defining Overactive Bladder as Hypersensitivity
- by Philip M. Hanno, MD, MPH

Minimally Invasive Therapy for Neurogenic Detrusor Overactivity: A Review
- by Karl-Erik Andersson, Roger Dmochowski and Alan Wein

A Randomized Controlled Study of Posterior Tibial Nerve Stimulation for Overactive Bladder
- by Paula Palma, MD, PhD. et al.

Efficacy and Tolerability of Add-On Trospium Chloride in Patients with Benign Prostate Syndrome and Overactive Bladder: A Noninterventional Trial Showing Use of Flexible Dosing
- by Ulrich Schwantes, PhD, et al.

The second-line management of idiopathic overactive bladder: What is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?

On the Origins of the Sensory Output from the Bladder: The Concept of Afferent Noise

A Review of Adherence to Drug Therapy in Patients with Overactive Bladder

Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study
- by Michael Chancellor, MD, et al.

Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release
- by Michael G. Oefelein, MD, et al.

Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery
- by Michael Chancellor, MD.

The evolution of transdermal therapy for overactive bladder
- by Peter K. Sand, MD

Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder
- by Michael K. Flynn, MD, et al.

InterStim Therapy: A Contemporary Approach to Overactive Bladder
- by Neeraj Kohli, MD, MBA and Danielle Patterson, MD

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years
- by Brian Olshansky, MD, et al.

Randomized Comparison of Tolterodine With Vaginal Estrogen Cream Versus Tolterodine Alone for the Treatment of Postmenopausal Women With Overactive Bladder Syndrome
- by Ling-Hong Tseng, MD, et al.

The role of industry funding in randomized controlled trials of antimuscarinic medications for overactive bladder
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

State of the Art Lecture: Bladder re-innervation: Can new nerves improve the function of the neurogenic bladder?
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Is ultrasound bladder wall thickness a better measure than urodynamics for overactive bladder symptoms?
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Urodynamics/Incontinence/Female Urology: Urodynamic Testing - Identification of Measures of Bladder Sensation in Patients with Overactive Bladder
- Session Highlight by Kathleen Kobashi, MD from the 2009 Annual Meeting of the American Urological Association (AUA)

Session Highlights from the Society for Urodynamics & Female Urology 2009 Winter Meeting
- Exclusive Coverage by UroToday Contributing Medical Editor, William Jaffe, MD

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at The National Institutes of Health (NIH) - UI Symposium
- Session Highlights Reported by Diane K. Newman

Drug Treatment - Lecture Series

- Presented by Karl-Erik Andersson, MD, PhD, and Christopher Chapple, MD, et al. at the Fourth International Consultation on Incontinence (ICI)

Drug Treatment - Committee Meeting Highlights

- Reported by William Jaffe, MD from the Fourth International Consultation on Incontinence (ICI)

Voiding Dysfunction Session Highlights

- From the American Urological Association 2008 Annual Meeting

Urodynamics and Reality

- Presented by Ed McGuire, MD, at the 32nd Winter Urologic Forum

Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder
- Presented at the European Association of Urology - 23rd Annual EAU Congress

International Consultation on Incontinence - ICI 2008
- Session Abstracts, Overactive Bladder